Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files Rare Disease Webinar Slides Final Feb 27 pdf
AMCP 2024 Share on: Monday, April 15 - Thursday, April 18, 2024 Conference website Research coauthored by RTI Health Solutions will be presented at AMCP 2024. If you are attending, please stop by our posters and see our research on Avelumab therapy and …
… and Analytic Methods The workshop will be a virtual webinar and will provide an opportunity for attendees to …
Join Our Mailing List Stay informed about upcoming webinars, see thought leadership from our experts, and receive periodic news and updates. Fill out the form below to sign up. By choosing to subscribe, you agree to our Data Protection Policy …
Vagus Nerve Stimulation: Cost-Effective Treatment for Drug-Resistant Epilepsy Share on: September 17, 2018 Patients with drug-resistant epilepsy (DRE) utilize more health care resources and face higher costs than patients who can control their condition …
… quality evidence in advance, and nimbly adjust to the final scope and label changes. …
Efficiency, Patient Access, and Costs Associated with Blood Platelet Processing Methods – New Research Share on: August 17, 2021 When a person donates blood platelets, those platelets become life-saving treatments for a variety of conditions. The amount …
… to editors and graphic designers to help you polish your final output. Our commitment to creating a productive and …
ENCePP Pharmacoepidemiology Methodological Standards Guide Revision 9 Released Share on: July 16, 2021 The ENCePP Guide on Methodological Standards in Pharmacoepidemiology was created and is maintained by members of the European Network of Centres for …
… Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related Dementias William L Herring, PhD Executive Director, Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, economic evaluations are …
… health records, claims and billing activities, product and disease registries, or health-monitoring devices) – this … population in the pivotal clinical study (e.g., stage of disease) and the population that informed instrument … BEST glossary to clarify PRO-related terminology. Read the final draft guidance here: …